BioForce Nanosciences Holdings, Inc.
BFNH · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $10 | $123 | $28 | $123 |
| SG&A Expenses | $10 | $123 | $28 | $123 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $106 | $0 | $106 | $0 |
| Operating Expenses | $116 | $123 | $133 | $123 |
| Operating Income | -$116 | -$123 | -$133 | $262 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | -$385 |
| Pre-Tax Income | -$116 | -$123 | -$133 | -$123 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$116 | -$123 | -$935 | -$123 |
| % Margin | – | – | – | – |
| EPS | -0.004 | -0.004 | -0.029 | -0.004 |
| % Growth | 5.4% | 87.2% | -590.5% | – |
| EPS Diluted | -0.004 | -0.004 | -0.029 | -0.004 |
| Weighted Avg Shares Out | 33,522 | 33,522 | 32,247 | 29,272 |
| Weighted Avg Shares Out Dil | 33,522 | 33,522 | 32,247 | 29,272 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$116 | -$123 | -$133 | -$123 |
| % Margin | – | – | – | – |